nicycive Therapeutics Received Decision To Grant European Patent Number EP3848040 Titled “LANTHANUM DIOXYCARBONATE AND USE (FOR TREATING PATIENTS WITH HYPERPHOSPHATEMIA)”
https://twitter.com/PatentGrants/status/1635726713815719936
Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
Gainers
PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.
Why Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers
Barnes & Noble Education, Inc. (NYSE: BNED) rose 25% to $2.15 in pre-market trading after the company posted better-than-expected quarterly sales.
Looking Into Unicycive Therapeutics’s Recent Short Interest
Unicycive Therapeutics’s (NASDAQ:UNCY) short percent of float has risen 54.69% since its last report. The company recently reported…
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday.
The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P 500 also rose, gaining, 0.35% to 4,059.80.
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.
The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500 also rose, gaining, 0.69% to 4,073.40.
Why Unicycive Therapeutics Stock Is Exploding Higher Monday
Unicycive Therapeutics Inc (NASDAQ: UNCY) shares are exploding higher Monday after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb, a phosphate binder that potently controls phosphate with just
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.